These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 39251878)

  • 1. Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine.
    Sierri G; Patrucco M; Ferrario D; Renda A; Comi S; Ciprandi M; Fontanini V; Sica FS; Sesana S; Costa Verdugo M; Kravicz M; Salassa L; Busnelli M; Re F
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(5):e1991. PubMed ID: 39251878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in biomimetic nanodelivery systems: New brain-targeting strategies.
    Liao J; Fan L; Li Y; Xu QQ; Xiong LY; Zhang SS; Liu JH; Xiao ZC; Zhang C; Yang J; Chen ZS; Xiao K; Wang TF; Lu Y
    J Control Release; 2023 Jun; 358():439-464. PubMed ID: 37169179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.
    Curtis C; Zhang M; Liao R; Wood T; Nance E
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27562224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Brain with Nanomedicine.
    Rueda F; Cruz LJ
    Curr Pharm Des; 2017; 23(13):1879-1896. PubMed ID: 28003011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of nanomedicines for neuron targeting.
    Garcia-Chica J; D Paraiso WK; Tanabe S; Serra D; Herrero L; Casals N; Garcia J; Ariza X; Quader S; Rodriguez-Rodriguez R
    Nanomedicine (Lond); 2020 Jul; 15(16):1617-1636. PubMed ID: 32618490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-ligand functionalized blood-to-tumor sequential targeting strategies in the field of glioblastoma nanomedicine.
    Martins C; Sarmento B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1893. PubMed ID: 37186374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated nanoparticle delivery systems: towards precision nanomedicine.
    Cheng R; Wang S
    Drug Deliv Transl Res; 2024 Nov; 14(11):3032-3054. PubMed ID: 38615157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases.
    Jo DH; Kim JH; Lee TG; Kim JH
    Nanomedicine; 2015 Oct; 11(7):1603-11. PubMed ID: 25989200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Targeting Nanomedicines: Pitfalls and Promise.
    Kakinen A; Jiang Y; Davis TP; Teesalu T; Saarma M
    Int J Nanomedicine; 2024; 19():4857-4875. PubMed ID: 38828195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
    Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine revolutionizes epilepsy treatment: overcoming therapeutic hurdles with nanoscale solutions.
    Li S; Zhang W; Zhu Y; Yao Q; Chen R; Kou L; Shi X
    Expert Opin Drug Deliv; 2024 May; 21(5):735-750. PubMed ID: 38787859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
    Srinivasarao DA; Lohiya G; Katti DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonviral nanoparticle gene delivery into the CNS for neurological disorders and brain cancer applications.
    Yang J; Luly KM; Green JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1853. PubMed ID: 36193561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The blood-brain barrier and beyond: Nano-based neuropharmacology and the role of extracellular matrix.
    Henrich-Noack P; Nikitovic D; Neagu M; Docea AO; Engin AB; Gelperina S; Shtilman M; Mitsias P; Tzanakakis G; Gozes I; Tsatsakis A
    Nanomedicine; 2019 Apr; 17():359-379. PubMed ID: 30759369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bio-Nano Toolbox for Precision Alzheimer's Disease Gene Therapy.
    Liu Y; Xia X; Zheng M; Shi B
    Adv Mater; 2024 Jul; 36(29):e2314354. PubMed ID: 38778446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment of CNS Disorders: Challenges and Possibilities.
    Sa P; Singh P; Dilnawaz F; Sahoo SK
    Curr Pharm Des; 2022; 28(33):2742-2757. PubMed ID: 35909283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming the Blood-Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours.
    Ferraris C; Cavalli R; Panciani PP; Battaglia L
    Int J Nanomedicine; 2020; 15():2999-3022. PubMed ID: 32431498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologics, theranostics, and personalized medicine in drug delivery systems.
    Puccetti M; Pariano M; Schoubben A; Giovagnoli S; Ricci M
    Pharmacol Res; 2024 Mar; 201():107086. PubMed ID: 38295917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles.
    Islam Y; Leach AG; Smith J; Pluchino S; Coxon CR; Sivakumaran M; Downing J; Fatokun AA; Teixidò M; Ehtezazi T
    Adv Sci (Weinh); 2021 Jun; 8(11):e2002085. PubMed ID: 34105297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.